Photo: mcw.edu
Feb 1, 2026, 11:32
Qizhen Shi։ A Padua Moment for Factor VIII Gene Therapy
Qizhen Shi, Professor at Medical College of Wisconsin, Program Co-Leader of Thrombosis and Hemostasis at Versiti Blood Research Institute, shared on LinkedIn:
”Honored to share that my Blood Commentary, ‘A Padua moment for factor VIII gene therapy,’ has now been published.
The Commentary discusses a newly engineered FVIII variant with improved secretion and cofactor activity, offering a Padua-like advance for hemophilia A gene therapy by enabling efficacy at substantially lower vector doses.
Congratulations to the authors of the original study, and thank you to the Blood editorial team for the invitation.”
Stay updated with Hemostasis Today.
-
Nov 18, 2026, 20:58Uma Vaidyanathan: When Hemoglobin Does Not Respond to Iron Therapy, Look Beyond Iron Deficiency
-
Nov 18, 2026, 20:57Jamil Rafiq: 5 Ways to Prevent Sample Haemolysis
-
Nov 18, 2026, 20:55Nasir Jamal: Plasmapheresis – Key Concepts at a Glance
-
Nov 18, 2026, 20:55Tarık Seller: Pulmonary Embolism – When a Blood Clot Becomes a Life-Threatening Emergency
-
Nov 18, 2026, 20:53Sandya Arunachalam: Bringing the Profession Together at the Haemostasis and Thrombosis Workshop
-
Nov 18, 2026, 15:11Vansh Yaduvanshi: Why Compatible Blood Groups Do Not Always Mean Compatible Blood
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons